Efficacy and safety of clindamycin phosphate 1.2%/tretinoin 0.025% formulation for the treatment of acne vulgaris: pooled analysis of data from three randomised, double-blind, parallel-group, phase III studies

Brigitte Dréno; Vincenzo Bettoli; Falk Ochsendorf; Alison M. Layton; Montserrat Perez; Rada Dakovic; Harald Gollnick

doi:10.1684/ejd.2014.2293

Efficacy and safety of clindamycin phosphate 1.2%/tretinoin 0.025% formulation for the treatment of acne vulgaris: pooled analysis of data from three randomised, double-blind, parallel-group, phase III studies

European Journal of Dermatology ◽

10.1684/ejd.2014.2293 ◽

2014 ◽

Vol 24 (2) ◽

pp. 201-209 ◽

Cited By ~ 17

Author(s):

Brigitte Dréno ◽

Vincenzo Bettoli ◽

Falk Ochsendorf ◽

Alison M. Layton ◽

Montserrat Perez ◽

...

Keyword(s):

Acne Vulgaris ◽

Pooled Analysis ◽

Phase Iii ◽

Efficacy And Safety ◽

Clindamycin Phosphate ◽

Double Blind ◽

Parallel Group ◽

Phase Iii Studies

Download Full-text

Efficacy and safety of novel clindamycin 1%/tretinoin 0.025% formulation for acne vulgaris: Pooled analysis of 3 phase III studies

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2012.12.063 ◽

2013 ◽

Vol 68 (4) ◽

pp. AB14

Keyword(s):

Acne Vulgaris ◽

Pooled Analysis ◽

Phase Iii ◽

Efficacy And Safety ◽

Phase Iii Studies

Download Full-text

Faculty Opinions recommendation of A phase III, randomized, double-blind, parallel-group, placebo-controlled, multicentre study to assess the efficacy and safety of the β₃ adrenoceptor agonist, mirabegron, in patients with symptoms of overactive bladder.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718020708.793482011 ◽

2013 ◽

Author(s):

Francisco Cruz

Keyword(s):

Overactive Bladder ◽

Multicentre Study ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Adrenoceptor Agonist ◽

Parallel Group

Download Full-text

Faculty Opinions recommendation of A phase III, randomized, double-blind, parallel-group, placebo-controlled, multicentre study to assess the efficacy and safety of the β₃ adrenoceptor agonist, mirabegron, in patients with symptoms of overactive bladder.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718020708.793480560 ◽

2013 ◽

Author(s):

Howard Goldman ◽

Alana M Murphy

Keyword(s):

Overactive Bladder ◽

Multicentre Study ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Adrenoceptor Agonist ◽

Parallel Group

Download Full-text

Faculty of 1000 evaluation for Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718030851.793482493 ◽

2013 ◽

Author(s):

Joanne Jordan ◽

Amanda Nelson

Keyword(s):

Clinical Trial ◽

Sustained Release ◽

Hip Osteoarthritis ◽

Randomised Clinical Trial ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

Parallel Group

Download Full-text

Faculty Opinions recommendation of Clindamycin phosphate 1·2%-benzoyl peroxide 3·0% fixed-dose combination gel has an effective and acceptable safety and tolerability profile for the treatment of acne vulgaris in Japanese patients: a phase III, multicentre, randomised, single-blinded, active-controlled, parallel-group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718499102.793503221 ◽

2015 ◽

Author(s):

Ichiro Kurokawa

Keyword(s):

Benzoyl Peroxide ◽

Acne Vulgaris ◽

Japanese Patients ◽

Fixed Dose Combination ◽

Phase Iii ◽

Fixed Dose ◽

Tolerability Profile ◽

Clindamycin Phosphate ◽

Parallel Group ◽

Dose Combination

Download Full-text

Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies

Breast Cancer Research and Treatment ◽

10.1007/s10549-010-1251-y ◽

2010 ◽

Vol 125 (3) ◽

pp. 755-765 ◽

Cited By ~ 15

Author(s):

Henri Roché ◽

Pierfranco Conte ◽

Edith A. Perez ◽

Joseph A. Sparano ◽

Binghe Xu ◽

...

Keyword(s):

Breast Cancer ◽

Performance Status ◽

Safety Data ◽

Metastatic Breast ◽

Pooled Analysis ◽

Phase Iii ◽

Efficacy And Safety ◽

Breast Cancer Patients ◽

Previously Treated ◽

Phase Iii Studies

Download Full-text

Efficacy and Safety of Secukinumab in Elderly Subjects with Moderate to Severe Plaque Psoriasis: A Pooled Analysis of Phase III Studies

Drugs & Aging ◽

10.1007/s40266-018-0520-z ◽

2018 ◽

Vol 35 (2) ◽

pp. 135-144 ◽

Cited By ~ 23

Author(s):

Andreas Körber ◽

Charis Papavassilis ◽

Vaishali Bhosekar ◽

Maximilian Reinhardt

Keyword(s):

Plaque Psoriasis ◽

Pooled Analysis ◽

Phase Iii ◽

Elderly Subjects ◽

Efficacy And Safety ◽

Severe Plaque Psoriasis ◽

Phase Iii Studies

Download Full-text

Efficacy and Safety of the Controlled-release Pregabalin Tablet (GLA5PR GLARS-NF1) and Immediate-release Pregabalin Capsule for Peripheral Neuropathic Pain: A Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Phase III Clinical Trial

Clinical Therapeutics ◽

10.1016/j.clinthera.2020.10.009 ◽

2020 ◽

Vol 42 (12) ◽

pp. 2266-2279

Author(s):

Min-Kyung Lee ◽

Younghoon Jeon ◽

Sang Sik Choi ◽

Pyung Bok Lee ◽

Yong-Chul Kim ◽

...

Keyword(s):

Clinical Trial ◽

Neuropathic Pain ◽

Controlled Release ◽

Immediate Release ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Peripheral Neuropathic Pain ◽

Phase Iii Clinical Trial ◽

Parallel Group

Download Full-text

Efficacy and safety of eslicarbazepine acetate as adjunctive therapy for refractory focal-onset seizures in children: A double-blind, randomized, placebo-controlled, parallel-group, multicenter, phase-III clinical trial

Epilepsy & Behavior ◽

10.1016/j.yebeh.2020.106962 ◽

2020 ◽

Vol 105 ◽

pp. 106962 ◽

Cited By ~ 3

Author(s):

Fenella Kirkham ◽

Stéphane Auvin ◽

Joana Moreira ◽

Helena Gama ◽

Amílcar C. Falcão ◽

...

Keyword(s):

Clinical Trial ◽

Adjunctive Therapy ◽

Phase Iii ◽

Efficacy And Safety ◽

Eslicarbazepine Acetate ◽

Double Blind ◽

Phase Iii Clinical Trial ◽

Multicenter Phase ◽

Parallel Group

Download Full-text

Consistent and significant improvement of nighttime voiding frequency (nocturia) with silodosin in men with LUTS suggestive of BPH: pooled analysis of three randomized, placebo-controlled, double-blind phase III studies

World Journal of Urology ◽

10.1007/s00345-013-1228-7 ◽

2014 ◽

Vol 32 (5) ◽

pp. 1119-1125 ◽

Cited By ~ 25

Author(s):

Andreas Eisenhardt ◽

Tim Schneider ◽

Francisco Cruz ◽

Matthias Oelke

Keyword(s):

Pooled Analysis ◽

Phase Iii ◽

Double Blind ◽

Phase Iii Studies

Download Full-text